Tissue Regenix Group plc (LON:TRX – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 37 ($0.48) and last traded at GBX 37 ($0.48), with a volume of 78975 shares. The stock had previously closed at GBX 40.50 ($0.53).
Tissue Regenix Group Price Performance
The company has a debt-to-equity ratio of 31.16, a quick ratio of 2.36 and a current ratio of 4.03. The stock has a market capitalization of £33.36 million, a PE ratio of -38.20 and a beta of 1.61. The business’s 50-day moving average price is GBX 51.88 and its 200 day moving average price is GBX 55.79.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Articles
- Five stocks we like better than Tissue Regenix Group
- Russell 2000 Index, How Investors Use it For Profitable Trading
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How is Compound Interest Calculated?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Capture the Benefits of Dividend Increases
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
